These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9017149)

  • 1. Does hepatitis B virus or hepatitis C virus infection influence CD4 count in HIV-positive individuals?
    Smiatacz T; Zielińska W
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):335-43. PubMed ID: 9017149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A; Mohraz M; Aghakhani A; Banifazl M; Eslamifar A; Khadem-Sadegh A; Velayati AA
    Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters.
    Beld M; Penning M; Lukashov V; McMorrow M; Roos M; Pakker N; van den Hoek A; Goudsmit J
    Virology; 1998 May; 244(2):504-12. PubMed ID: 9601518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
    J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic hepatitis B and C in HIV-infected patients].
    Opravil M; Hunziker R; Lüthy R; Grob PJ
    Dtsch Med Wochenschr; 1998 Jun; 123(24):753-60. PubMed ID: 9672477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
    Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
    J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult hepatitis B in HIV-HCV coinfected patients.
    Piroth L; Lafon ME; Binquet C; Bertillon P; Gervais A; Lootvoet E; Lang JM; De Jaureguiberry JP; Chene G; Leport C;
    Scand J Infect Dis; 2008; 40(10):835-9. PubMed ID: 18609222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
    Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection.
    Netski DM; Mosbruger T; Astemborski J; Mehta SH; Thomas DL; Cox AL
    J Infect Dis; 2007 Mar; 195(6):857-63. PubMed ID: 17299716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
    Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
    Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
    Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E
    Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients.
    Neau D; Winnock M; Galpérine T; Jouvencel AC; Castéra L; Legrand E; Tranchant E; Balestre E; Lacoste D; Ragnaud JM; Dupon M; Lafon ME; Dabis F;
    HIV Med; 2004 May; 5(3):171-3. PubMed ID: 15139983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological status for HBV and HCV infection in anti-HIV seropositive and seronegative intravenous drug abusers.
    De Mercato R; Oriani G; Guarnaccia D; Romano A; Ciampi R; Cantiello JP; Di Pietro M; Celentano U; Riganti C; Romano C
    Boll Soc Ital Biol Sper; 1991 Jan; 67(1):103-8. PubMed ID: 1909531
    [No Abstract]   [Full Text] [Related]  

  • 17. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis and posthepatic cirrhosis in AIDS].
    Bierhoff E; Fischer HP; Pfeifer U; Rockstroh J; Spengler U
    Verh Dtsch Ges Pathol; 1995; 79():249-53. PubMed ID: 8600688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
    Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A
    Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy.
    Filippini P; Coppola N; Pisapia R; Scolastico C; Marrocco C; Zaccariello A; Nacca C; Sagnelli C; De Stefano G; Ferraro T; De Stefano C; Sagnelli E
    AIDS; 2006 Jun; 20(9):1253-60. PubMed ID: 16816553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.